Protease inhibitor for chronic pancreatitis: Where do we go next?

Su1186 ANTITUMOR EFFECT OF TALAPORFIN PHOTO DYNAMIC THERAPY (PDT) COMBINED WITH THE IMMUNE CHECKPOINT INHIBITOR

Tu1567 ADAVOSERTIB, A WEE1 INHIBITOR, AS A NOVEL SENOLYTICS, TARGETS THE VULNERABILITY OF LIVER CANCER INDUCED BY EPIRUBICIN

Tu1416 RADIOFREQUENCY ABLATION IN COMBINATION WITH AN ANTI-PDL1 CHECKPOINT INHIBITOR REDUCES TUMOR GROWTH AND ENHANCES ANTI TUMOR IMMUNITY IN A SYNGENEIC ...

Mo1567 TREATMENT OUTCOMES OF IMMUNE CHECKPOINT INHIBITOR (ICI) HEPATITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS

April 17, 2024 5 min read ...

High-dose proton pump inhibitor (PPI) therapy has been recommended to prevent rebleeding of high-risk peptic ulcer (PU) after hemostasis. Vonoprazan has ...

Altered microbial transcription in long-term proton pump inhibitor usage: findings from a US cohort study